Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial
Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's deployment without altering the study information.SummaryDifference0.0%

- Check8 days agoChange DetectedA new funding line indicating the 2016 U.S. NIH grant/contract was added to the study record. This addition provides funding attribution within the study's details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.5 is now shown, replacing the previous v3.6.4, indicating a minor site update to the page template.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page’s revision tag in the footer was updated from v3.6.3 to v3.6.4, reflecting a small template/content update.SummaryDifference0.0%

- Check58 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a small platform update with no changes to the study details or navigation visible to users.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 in the page footer, indicating a minor version update. The change does not modify page content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.